Advertisement

Picture EBD Group ChinaBio Partnering Forum 2020 Digital Event CBPF2020 650x80
Document › Details

Kinaxo Biotechnologies GmbH. (10/11/10). "Press Release: Kinaxo Enters Agreement with Bristol-Myers Squibb Company". Martinsried.

Organisations Organisation Kinaxo Biotechnologies GmbH
  Today Evotec (München) GmbH
  Group Evotec (Group)
  Organisation 2 Bristol-Myers Squibb Co. (BMS) (NYSE: BMY)
  Group Bristol-Myers Squibb (BMS) (Group)
Products Product proteomic services
  Product 2 drug discovery services
Index term Index term BMS–Kinaxo: drug discovery services, 201010– collab Kinaxo to apply chemical proteomics technologies to deconvolute molecular targets of BMS compounds
Person Person Fritz, Jutta (Blackfield 201307 before Kinaxo 200901– Head Business Development before Max Planck Innovation)
     


KINAXO Biotechnologies GmbH announced today that Bristol-Myers Squibb Company (NYSE:BMY) has chosen KINAXO to support several of its drug discovery programs. Under the terms of the agreement, KINAXO will apply its chemical proteomics technologies to deconvolute molecular targets of compounds currently undergoing discovery research at Bristol-Myers Squibb to enable more informed decisions at various stages of the drug discovery process, such as selecting the right compound for clinical development.

Dr Jutta Fritz, Head of Business Development at KINAXO commented: "We are very pleased to collaborate with Bristol-Myers Squibb, one of the most prestigious pharmaceutical companies in the world. We are looking forward to building a productive partnership with Bristol-Myers Squibb, and consider this move to be a major milestone in expanding our business in the United States."


About KINAXO

KINAXO Biotechnologies is a privately-held biotechnology company based in Munich/Martinsried, Germany. KINAXO's technology platform offers solutions for drug mode-of-action analysis, cellular target profiling, target deconvolution, drug repositioning and biomarker discovery. KINAXO maintains several collaborations with global pharmaceutical companies, such as Johnson & Johnson, Daiichi-Sankyo, Bayer, Roche and Boehringer Ingelheim. For more information, please visit www.kinaxo.com.

   
Record changed: 2017-04-02

Advertisement

Picture [iito] Männer Ballett 650x80px

More documents for Evotec (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2020 Digital Event CBPF2020 650x80




» top